The global digital pathology market is estimated to be $191.00 million in 2012, and is poised to grow at a CAGR of 12% to reach $336.61 million by 2017.
(PRWEB) February 19, 2013
Digital pathology is currently gaining momentum as pathologists are seeking to achieve workflow efficiency and cost cutting in the pathological process. It provides ready access to premium quality slide images, enabling better and fast diagnosis, as well as preservation of these digital slides for future reference. The digital pathology market is driven by the factors such as reduction in laboratory expenses, improvement in operational efficiency, and treatment decisions and patient care. The rising prevalence of cancer, increasing trends in drug development, companion diagnostics, and ease of consultation are the major drivers that are slated to propel this market. However, a few pivotal factors restraining the growth of this market are FDA regulations in some regions, high cost of Digital Pathology Systems (DPS), technological problems, and conservative outlook of pathologists. There are a few well-established firms and several small ones operating in this industry.
The global digital pathology market is broadly segmented into two categories based on its products and application. The product category includes scanners, analytics (visualization software, information management systems and image analysis platforms), storage and communication (sharing services, software), while the application category comprises human pathology and animal pathology. Both these markets are dominated by North America in 2012, followed by Europe, Asia, and Rest of the World (RoW).
The global digital pathology market is dominated by the North America, followed by Europe, Asia, and Rest of the World. North America will continue to lead the digital pathology market for the next five years in spite of stringent FDA regulations and premarketing approvals. This is due to the increasing adoption of digital pathology systems by research labs, pharmaceutical and biotechnology companies, clinical research institutes, contract research organizations, etc. Moreover, the capacity to spend money is also driving the growth in this geography. However, a robust growth rate will be observed in Europe as vendors and manufacturers will be seen turning towards the region for regulatory reliefs. The Asian region's contribution to the global digital pathology market is also expected to pick up in the coming years, as the technology gets more recognition and becomes more cost effective.
This research report categorizes the global digital pathology market into different segments based on its products and application.
Leading players featured in the report include 3Dhistech, Ltd, Aperio Technologies, Inc., Apollo Pacs, Inc., Aurora Interactive, Ltd., Corista, Llc, Definiens Ag, Digipath, Inc., Hamamatsu Photonics K.K., Huron Technologies International, Inc., Indica Labs, Inc., Leica Microsystems Gmbh, Ligolab, Llc, Mikroscan Technologies, Inc., Nikon Instruments, Inc., Omnyx, Llc, Pathcentral, Inc., Pathxl, Pixcelldata, Ltd., Sunquest Information Systems, Ventana Medical Systems, Inc., and Visiopharm .
For more information please visit http://www.researchandmarkets.com/research/rlpjbf/digital_pathology
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716